Medtronic Agrees to Buy Contego Medical to Boost Stroke Prevention Tools
Minneapolis, Monday, 16 November 2026.
Medtronic plans to acquire Contego Medical for $380 million, securing an FDA-approved carotid therapy that achieved zero strokes and zero heart attacks at 30 days in clinical trials.